To study the efficacy of Dhatriadi eyedrop, Shigrupatradi eyedrop and Triphaladi Churna for the management of Amaja Abhishyanda (Acute infective Conjunctivites )

Efficacy of Dhatriadi Eye Drop, Shigrupatradi Eye Drop with Triphaladi Churna in the management of Amaja Abhishyanda (Acute Infective Conjunctivitis)- An open labelled randomized clinical trial. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/08/056217

Enrollment

100

Registered

2023-08-07

Start date

Unknown

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H102- Other acute conjunctivitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients between 18 to 50 years of age with irrespective of Gender, Occupation, Religion, Socio-Economic status. Patients having minimum two Clinical symptoms of Amaja Abhishyanda. Symptoms developed within less than 5 days.

Exclusion criteria

Exclusion criteria: Patients having complications of corneal involvement like Marginal Corneal Ulcer, Dacryocystitis, Trachoma, Keratoconjunctivitis sicca, Vernal Keratoconjunctivitis, Giant papillary conjunctivitis, Atopic Keratoconjunctivitis, Pterygium. Patient with the complain of Recurrent allergic conjunctivitis, Uncontrolled systemic disease condition. Pregnant and lactating mother must be excluded.

Design outcomes

Primary

Measure	Time frame
Pacification in the clinical features of Amaja Abhishyanda.Timepoint: on 0 & 14th day	—

Secondary

Measure	Time frame
Recurrence of sign & symptoms of Amaja Abhishyanda (Acute Infective Conjunctivitis)Timepoint: 21st & 30th day	—

Countries

India

Contacts

Public ContactAmeesha Rajeshkumar Shrigod

Institute of Teaching and Research in Ayurveda

drdeep29@gmail.com7737379173

Outcome results